Clene Inc. Rallies 13.4% as Investors Back Its Oral Neuro‑Therapeutic Pipeline
Clene Inc. rallies 13.37% in one day, sparking renewed interest in its oral nanotech neurodegenerative platform and potential upside to $10‑12.
3 minutes to read
CLENE INC